Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana (DetI-MTTT)
Malaria Asymptomatic Parasitaemia
About this trial
This is an interventional health services research trial for Malaria Asymptomatic Parasitaemia focused on measuring Malaria, Determine, impact, mass testing and treatment, children under 5, Pakro Ghana
Eligibility Criteria
Inclusion Criteria:
Overall inclusion criteria for MTTT:
- Be aged 2 months or older
- Be resident in the study area
- Have completed and signed the consent for adults or assent form for children 12-17 years.
Inclusion Criteria for children in the subgroup study:
- Be age range 6 months to 14 years
- Be resident in the study area for the period of the study.
- Be willing to participate
- Parent or guardian have completed and signed consent form
- Provided assent for children 12-17 years
Exclusion Criteria:
- If an individual intents to stay less than one year in the study site
- Be absent at some time because he/she is schooling in a boarding school
- Has a life threatening illness (excluding malaria).
Sites / Locations
- Noguchi Memorial Institute for Medical Research
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Arm 1 (intervention arm)
Arm 2 (control arm)
Arm 1 or the intervention arm will involve seven communities: 4-monthly mass screening, and treatment of those who test positive by CHWs will be conducted. Febrile cases will be tested and treated by CHWs any time
Arm 2 or the Control arm will involve 2 communities: mass screening and treatment only done at baseline and at evaluation. Febrile cases will be tested and treated by CHWs any time.